SEC Form 4 · accession 0001209191-15-051181
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric David
Officer — CSO & EVP Pre-Clinical Dev
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 7:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Rignt to Buy)F1,F2 | $4.92 | Jun 4, 2015 | A | 130,000 | A | — | Jun 4, 2025 | Common Stock | 130,000 | 130,000 | D |
Explanation of responses
- F1Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors.
- F225% of the option shares vest and become exercisable on June 4, 2016 and the remaining shares vest in 12 equal quarterly installments thereafter.